PMID: 26324046Sep 2, 2015Paper

Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells

Current Topics in Medicinal Chemistry
Nicolas Sluis-Cremer

Abstract

While combination antiretroviral therapy (cART) can drive HIV-1 RNA levels to < 50 copies/mL in patient plasma, most infected individuals continue to harbor low-level persistent viremia. Latently infected resting CD4+ T cells are thought to constitute the major reservoir of HIV-1 persistence. In this reservoir, the integrated provirus remains transcriptionally silent as long as the host cell is in a resting state. On discontinuation of cART, these viruses can reactivate and lead to waves of de novo infection events. The prevailing hypothesis in the field is that molecules that reactivate latent HIV-1 infection will purge this reservoir by inducing transcription of the latent provirus, thereby causing cells to undergo apoptosis. This review article summarizes the results of all therapeutic approaches that have been clinically evaluated for their potential to reverse HIV latency.

Citations

Jun 28, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Noemia S LimaLydie Trautmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Nature Reviews. Microbiology
Yefei HanRobert F Siliciano
Retrovirology
Carine Van LintAlessandro Marcello
Current Opinion in Infectious Diseases
Joel N BlanksonRobert F Siliciano
JAMA : the Journal of the American Medical Association
D V HavlirJ K Wong
© 2021 Meta ULC. All rights reserved